Frederick E. Tan
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
- Cell Biology top 10%
- Hippo pathway signaling and YAP/TAZ
Papers in
-
- Protease and Inhibitor Mechanisms 2
- MicroRNA in disease regulation 2
-
- Nanoparticle-Based Drug Delivery 3
- Co-authors
- Róbert Langer (3 shared papers)Ying Chau (3 shared papers)Yunjiang Qiu (1 shared paper)Zhen Ye (1 shared paper)Shenghong Ma (1 shared paper)Kimberly C. Lin (1 shared paper)Steven W. Plouffe (1 shared paper)Bing Ren (1 shared paper)
- Journals
- Molecular Cell (2 papers)Nature Structural & Molecular Biology (1 paper)Bioconjugate Chemistry (1 paper)Nature Communications (1 paper)Cancer Research (1 paper)
- Partner nations
- United StatesGermanySingapore
In The Last Decade
Frederick E. Tan
9 papers receiving 558 citations
Peers
Comparison fields: 5 of 52
- Biomaterials 139
- Cell Biology 148
- Molecular Medicine 37
- Pharmaceutical Science 31
- Cancer Research 47
Countries citing papers authored by Frederick E. Tan
This map shows the geographic impact of Frederick E. Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederick E. Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederick E. Tan more than expected).
Fields of papers citing papers by Frederick E. Tan
This network shows the impact of papers produced by Frederick E. Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederick E. Tan. The network helps show where Frederick E. Tan may publish in the future.
Co-authors
The 25 scholars most cited alongside Frederick E. Tan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 193 | |
| 2 | 2004 | 154 | |
| 3 | 2006 | 81 | |
| 4 | 2020 | 69 | |
| 5 | 2014 | 25 | |
| 6 | 2016 | 21 | |
| 7 | 2018 | 15 | |
| 8 | 2021 | 7 | |
| 9 | 2022 | 5 | |
| 10 | In vitro and in vivo investigation of new tumortargeting conjugates with MMP sensitive linkers | 2004 | 0 |
| 11 | 2025 | 0 |
About Frederick E. Tan
Frederick E. Tan is a scholar working on Cancer Research, Biomaterials, Molecular Biology, Genetics and Cell Biology, having authored 11 papers that have together received 570 indexed citations. Recurring topics across this work include RNA Research and Splicing (4 papers), Nanoparticle-Based Drug Delivery (3 papers), Protease and Inhibitor Mechanisms (2 papers), MicroRNA in disease regulation (2 papers), Pluripotent Stem Cells Research (1 paper), Epigenetics and DNA Methylation (1 paper), RNA and protein synthesis mechanisms (1 paper) and Glioma Diagnosis and Treatment (1 paper). The work is most often cited by research in Biomaterials (139 citations), Cell Biology (148 citations), Molecular Medicine (37 citations), Pharmaceutical Science (31 citations) and Cancer Research (47 citations). Frederick E. Tan has collaborated with scholars based in United States, Germany and Singapore. Frequent co-authors include Róbert Langer, Ying Chau, Yunjiang Qiu, Zhen Ye, Shenghong Ma, Kimberly C. Lin, Steven W. Plouffe, Bing Ren, Kun‐Liang Guan and Gene Wei-Ming Yeo. Their work appears in journals such as Molecular Cell, Nature Structural & Molecular Biology, Bioconjugate Chemistry, Nature Communications and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.